Rezolve Ai criticizes Commerce.com poison pill adoption
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/22/2026
- Wall St futures edge lower as caution builds ahead of Big Tech earnings
- Oil climbs over 4% to near six-week high as conflict threatens key oil transit routes
- Chip stocks extend global rebound following last week's rout
- Citi's Chew says U.S. stock positioning unwind may not be over
- Adobe, Salesforce and Intuit fall as Morgan Stanley begins cautious coverage
- Emirates refusing to take delivery of first 10 Boeing 777X jets
- Intersnack to acquire Utz Brands at $14.25 per share in go-private deal
- Wall St ends higher on chip stocks recovery; earnings in focus
- Palo Alto Networks to acquire Embrace to expand observability tools
- Myriad Genetics launches four-in-one prenatal genetic screen
Rezolve Ai Slams Commerce.com Board’s "Desperate" Poison Pill That Will Dilute Shareholders and Stagnate Growth Further
April 14, 2026 1:32 PM EDTLabels Tactic a "White Flag" Following Prolonged Equity Collapse and No Clear Recovery Plan
Calls Into Question Boards Competence Ahead of May 14 Election
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Rezolve Ai PLC (NASDAQ: RZLV), a global leader in AI-powered commerce, today responded to the Commerce.com, Inc. (Nasdaq: CMRC) Board of Directors adoption of a stockholder rights plan (Poison Pill or Rights Plan).
Rezolve Ai views this as a transparent attempt by a failing Board to entrench itself and prevent... More
